Influence of an e-mail with a drug information attachment on sales of prescribed drugs: a randomized controlled study
2007

Impact of Email Drug Information on Prescription Sales

Sample size: 119 publication Evidence: moderate

Author Information

Author(s): Edward Christina, Himmelmann Anders, Wallerstedt Susanna M

Primary Institution: Department of Health, Pharmaceutical Unit, Regionens hus, Göteborg, Sweden

Hypothesis

Does an email with a drug information attachment affect the sales of prescribed drugs?

Conclusion

An email with a drug information attachment may influence sales of prescribed drugs, but the design of the attachment does not seem to matter.

Supporting Evidence

  • The absolute change in percentage rizatriptan was greater in the intervention groups compared to the control group.
  • No difference in sales was found between the two different email attachment designs.
  • The study involved a total of 119 primary care units in western Sweden.

Takeaway

Sending doctors an email with drug information can help them sell more of a specific medicine, but it doesn't matter how long the email is.

Methodology

The study randomized 119 heads of primary care units to receive different email attachments or no information, then compared changes in drug sales.

Potential Biases

The forwarding process of the emails may have influenced the results, as control group doctors might have received the information.

Limitations

The study only assessed short-term effects on sales and did not confirm if the emails reached the prescribing doctors.

Participant Demographics

Heads of primary care units in western Sweden.

Statistical Information

P-Value

0.031

Confidence Interval

25th – 75th percentile: -3 – 7

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1472-6904-7-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication